Anti-ALK autoantibodies in patients with ALK-positive Non-Small Cell Lung Cancer (NSCLC): A monocentric experience

Authors: Parisi, Claudia, Benitez, José Carlos, Lecourt, Hélène, dall’Olio, Filippo Gustavo, Aldea, Mihaela, Blanc-Durand, Felix, Vergé, Véronique, Quivoron, Cyril, Naltet, Charles, Abdayem, Pamela, Lavaud, Pernelle, Ghigna, Maria Rosa, Friboulet, Luc, Loriot, Yohann, De Botton, Stéphane, Ribrag, Vincent, Ardizzoni, Andrea, Planchard, David, Soria, Jean-Charles, Barlesi, Fabrice, Besse, Benjamin

Source: In The Journal of Liquid Biopsy December 2024 6

Early monitoring of plasma KRAS G12C with digital PCR predicts antitumor response to immunotherapy or sotorasib in advanced NSCLC: A brief report

Authors: De Giglio, Andrea, Zacchini, Federico, Venturi, Giulia, Di Federico, Alessandro, Parisi, Claudia, Dall’Olio, Filippo Gustavo, Ricciotti, Ilaria, Favorito, Valentina, Gagliano, Ambrogio, De Biase, Dario, Maloberti, Thais, Altimari, Annalisa, Gruppioni, Elisa, Tallini, Giovanni, Melotti, Barbara, Sperandi, Francesca, Gelsomino, Francesco, Montanaro, Lorenzo, Ardizzoni, Andrea

Source: In The Journal of Liquid Biopsy December 2024 6

Circulating tumor DNA to guide diagnosis and treatment of localized and locally advanced non-small cell lung cancer

Authors: Marinello, Arianna, Tagliamento, Marco, Pagliaro, Arianna, Conci, Nicole, Cella, Eugenia, Vasseur, Damien, Remon, Jordi, Levy, Antonin, Dall’Olio, Filippo Gustavo, Besse, Benjamin

Source: In Cancer Treatment Reviews September 2024 129

RET-MAP: An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion

Authors: Aldea, Mihaela, Marinello, Arianna, Duruisseaux, Michael, Zrafi, Wael, Conci, Nicole, Massa, Giacomo, Metro, Giulio, Monnet, Isabelle, Gomez Iranzo, Patricia, Tabbo, Fabrizio, Bria, Emilio, Guisier, Florian, Vasseur, Damien, Lindsay, Colin R., Ponce-Aix, Santiago, Cousin, Sophie, Citarella, Fabrizio, Fallet, Vincent, Minatta, Jose Nicolas, Eisert, Anna, de Saint Basile, Hortense, Audigier-Valette, Clarisse, Mezquita, Laura, Calles, Antonio, Mountzios, Giannis, Tagliamento, Marco, Remon Masip, Jordi, Raimbourg, Judith, Terrisse, Safae, Russo, Alessandro, Cortinovis, Diego, Rochigneux, Philippe, Pinato, David James, Cortellini, Alessio, Leonce, Camille, Gazzah, Anas, Ghigna, Maria-Rosa, Ferrara, Roberto, Dall’Olio, Filippo Gustavo, Passiglia, Francesco, Ludovini, Vienna, Barlesi, Fabrice, Felip, Enriqueta, Planchard, David, Besse, Benjamin

Source: In Journal of Thoracic Oncology May 2023 18(5):576-586

Tumor infiltrating lymphocytes (TILs) as a predictive biomarker of response to checkpoint blockers in solid tumors: A systematic review

Authors: Presti, Daniele, Dall’Olio, Filippo Gustavo, Besse, Benjamin, Ribeiro, Joana Mourato, Di Meglio, Antonio, Soldato, Davide

Source: In Critical Reviews in Oncology / Hematology September 2022 177

Molecular and Genetic Advances in Small Cell Lung Cancer Landscape: From Homogeneity to Diversity.

Authors: Zullo, Lodovica^1,2 (AUTHOR) filippogustavo.dall-olio@gustaveroussy.fr, Dall'Olio, Filippo Gustavo² (AUTHOR), Rossi, Giovanni³ (AUTHOR) giovanni.rossi@hsanmartino.it, Dellepiane, Chiara³ (AUTHOR) chiara.dellepiane@hsanmartino.it, Barletta, Giulia³ (AUTHOR) giulia.barletta@yahoo.it, Bennicelli, Elisa³ (AUTHOR) elisa.bennicelli@hsanmartino.it, Ingaliso, Marta⁴ (AUTHOR) marta.ingaliso@alice.it, Tagliamento, Marco^5,6 (AUTHOR), Genova, Carlo^5,6 (AUTHOR) carlo.genova@hsanmartino.it

Source: International Journal of Molecular Sciences. Jan2024, Vol. 25 Issue 1, p224. 18p.

Subject Terms: *SMALL cell lung cancer, *HOMOGENEITY

First-line pembrolizumab in advanced non–small cell lung cancer patients with poor performance status

Authors: Facchinetti, Francesco, Mazzaschi, Giulia, Barbieri, Fausto, Passiglia, Francesco, Mazzoni, Francesca, Berardi, Rossana, Proto, Claudia, Cecere, Fabiana Letizia, Pilotto, Sara, Scotti, Vieri, Rossi, Sabrina, Del Conte, Alessandro, Vita, Emanuele, Bennati, Chiara, Ardizzoni, Andrea, Cerea, Giulio, Migliorino, Maria Rita, Sala, Elisa, Camerini, Andrea, Bearz, Alessandra, De Carlo, Elisa, Zanelli, Francesca, Guaitoli, Giorgia, Garassino, Marina Chiara, Ciccone, Lucia Pia, Sartori, Giulia, Toschi, Luca, Dall’Olio, Filippo Gustavo, Landi, Lorenza, Pizzutilo, Elio Gregory, Bartoli, Gabriele, Baldessari, Cinzia, Novello, Silvia, Bria, Emilio, Cortinovis, Diego Luigi, Rossi, Giulio, Rossi, Antonio, Banna, Giuseppe Luigi, Camisa, Roberta, Di Maio, Massimo, Tiseo, Marcello

Source: In European Journal of Cancer May 2020 130:155-167

Clinical significance of ROS1 5’ deletions in non-small cell lung cancer

Authors: Capizzi, Elisa, Dall’Olio, Filippo Gustavo, Gruppioni, Elisa, Sperandi, Francesca, Altimari, Annalisa, Giunchi, Francesca, Fiorentino, Michelangelo ^*, Ardizzoni, Andrea

Source: In Lung Cancer September 2019 135:88-91

Genomic landscape of liquid biopsy mutations in TP53 and DNA damage genes in cancer patients.

Authors: Vasseur, Damien, Arbab, Ahmadreza, Giudici, Fabiola, Marzac, Christophe, Michiels, Stefan, Tagliamento, Marco, Bayle, Arnaud, Smolenschi, Cristina, Sakkal, Madona, Aldea, Mihaela, Sassi, Hela, Dall'Olio, Filippo Gustavo, Pata-Merci, Noémie, Cotteret, Sophie, Fiévet, Alice, Auger, Nathalie, Friboulet, Luc, Facchinetti, Francesco, Géraud, Arthur, Ponce, Santiago

Source: NPJ Precision Oncology; 2/26/2024, Vol. 8 Issue 1, p1-10, 10p

Subject Terms: CANCER genes, DNA damage, CANCER patients, CELL-free DNA, GENETIC mutation

Distinguishing between immune-related pneumonitis and disease progression in advanced Non Small Cell Lung Cancer treated with PD-1 inhibitors: Can serum tumour markers have a role?

Authors: Dall'Olio, Filippo Gustavo, Brocchi, Stefano, Massucci, Maria, Sperandi, Francesca, Melotti, Barbara, Ardizzoni, Andrea

Source: In European Journal of Cancer May 2018 95:127-129

Response to Osimertinib in Choroidal Metastases from EGFRmt T790M–Positive Non–Small Cell Lung Adenocarcinoma

Authors: Dall’Olio, Filippo Gustavo, Ruatta, Celeste, Melotti, Barbara, Sperandi, Francesca, Ciardella, Antonio Pasquale, Ardizzoni, Andrea

Source: In Journal of Thoracic Oncology October 2017 12(10):e165-e167

Quality of life assessment in renal cell carcinoma Phase II and III clinical trials published between 2010 and 2020: a systematic review.

Authors: Rizzo, Alessandro, Mollica, Veronica, Dall'Olio, Filippo Gustavo, Ricci, Angela Dalia, Maggio, Ilaria, Marchetti, Andrea, Rosellini, Matteo, Santoni, Matteo, Ardizzoni, Andrea, Massari, Francesco

Source: Future Oncology; Jul2021, Vol. 17 Issue 20, p2671-2681, 11p

Immortal time bias in the association between toxicity and response for immune checkpoint inhibitors: a meta-analysis.

Authors: Dall'Olio, Filippo Gustavo, Rizzo, Alessandro, Mollica, Veronica, Massucci, Maria, Maggio, Ilaria, Massari, Francesco

Source: Immunotherapy (1750743X); Feb2021, Vol. 13 Issue 3, p257-270, 14p

Percutaneous radiofrequency ablation in intrahepatic cholangiocarcinoma: a retrospective single-center experience.

Authors: Brandi, Giovanni, Rizzo, Alessandro, Dall’Olio, Filippo Gustavo, Felicani, Cristina, Ercolani, Giorgio, Cescon, Matteo, Frega, Giorgio, Tavolari, Simona, Palloni, Andrea, De Lorenzo, Stefania, Abbati, Francesca, Mollica, Veronica, Ricci, Angela Dalia, Serra, Carla

Source: International Journal of Hyperthermia; 2020, Vol. 37 Issue 1, p479-485, 7p

Cardiac Toxicity From Afatinib in EGFR-Mutated NSCLC: A Rare But Possible Side Effect

Authors: Nuvola, Giacomo, Dall'Olio, Filippo Gustavo, Melotti, Barbara, Sperandi, Francesca, Ardizzoni, Andrea

Source: In Journal of Thoracic Oncology July 2019 14(7):e145-e146

Arterial Embolization During Programmed Death-1 Inhibitor Treatment: An Unexpected Finding

Authors: Dall’Olio, Filippo Gustavo, Sperandi, Francesca, Rihawi, Karim, Gargiulo, Mauro, Melotti, Barbara, Brocchi, Stefano, Gelsomino, Francesco, Ardizzoni, Andrea

Source: In Journal of Thoracic Oncology December 2018 13(12):e247-e248

This result is not displayed to guests.
Login for full access.

Discontinuation of immunotherapy over 2 years for patients with non–small cell lung cancer (NSCLC): A search for predictors.

Authors: Cascetta, Priscilla¹ (AUTHOR), Reni, Anna¹ (AUTHOR), Facchinetti, Francesco² (AUTHOR), Meyer, May-Lucie¹ (AUTHOR), Riudavetz, Mariona¹ (AUTHOR), Aldea, Mihaela³ (AUTHOR), Dall'Olio, Filippo Gustavo⁴ (AUTHOR), Marinello, Arianna¹ (AUTHOR), Tagliamento, Marco⁵ (AUTHOR), Remon Masip, Jordi⁶ (AUTHOR), Besse, Benjamin⁵ (AUTHOR), Planchard, David⁷ (AUTHOR), Barlesi, Fabrice⁵ (AUTHOR), Derosa, Lisa⁸ (AUTHOR)

Source: Journal of Clinical Oncology. 2023 Supplement 16, Vol. 41, p2661-2661. 1p.

Association of ctDNA tumor fraction with survival in advanced non-small cell lung cancer (NSCLC) treated with maintenance durvalumab in the UNICANCER SAFIR02-Lung/IFCT1301 trial.

Authors: Dall'Olio, Filippo Gustavo¹ (AUTHOR), Vasseur, Damien² (AUTHOR), Karimi, Maryam³ (AUTHOR), Michiels, Stefan⁴ (AUTHOR), Lacroix, Ludovic² (AUTHOR), Tomasini, Pascale⁵ (AUTHOR), Raimbourg, Judith⁶ (AUTHOR), pata-Merci, Noemie⁷ (AUTHOR), Daniel, Catherine⁸ (AUTHOR), Janicot, Henri⁹ (AUTHOR), Madroszyk, Anne¹⁰ (AUTHOR), Audigier-Valette, Clarisse¹¹ (AUTHOR), Bieche, Ivan¹² (AUTHOR), Mazieres, Julien¹³ (AUTHOR), MORO SIBILOT, Denis Lucien¹⁴ (AUTHOR), Jimenez, Marta¹⁵ (AUTHOR), Soria, Jean-Charles¹⁶ (AUTHOR), Westeel, Virginie¹⁷ (AUTHOR), Barlesi, Fabrice¹⁸ (AUTHOR), Besse, Benjamin¹⁹ (AUTHOR)

Source: Journal of Clinical Oncology. 2023 Supplement 16, Vol. 41, p2516-2516. 1p.

Role of PD-L1 assessment in advanced NSCLC: does it still matter?

Authors: Rizzo, Alessandro, Dall'Olio, Filippo Gustavo, Altimari, Annalisa, Giunchi, Francesca, Ardizzoni, Andrea

Source: Anti-Cancer Drugs; Nov2021, Vol. 32 Issue 10, p1084-1085, 2p